Acitretin
- TRADE NAMES: Neotigason (Actavis); Soriatane (Stiefel)
- INDICATIONS: Psoriasis
- CLASS: Antipsoriatic agent, Retinoid
- HALF-LIFE: 49 hours
Alcohol, Bexarotene, Chloroquine, Cholestyramine, Corticosteroids, Coumarins, Danazol, Demeclocycline, Doxycycline, Ethanolamine, Isotretinoin, Lithium, Lymecycline, Medroxyprogesterone, Methotrexate, Minocycline, Oxytetracycline, Phenytoin, Progestins, St John's Wort, Tetracycline, Tigecycline, Vitamin A
PREGNANCY CATEGORY: X
Oral retinoids can cause birth defects, and women should avoid acitretin when pregnant or trying to conceive.
See full prescribing information for complete boxed warning.
Please login to see the rest of this drug profile
Click on the DRUG REVIEW ARTICLE tab (above) to see a review of acitretin in the Taylor & Francis journal Expert Opinion on Drug Safety. (Note that non-subscribers to the journal will only be able to see an abstract of the article.)
Page last updated 10/29/2020
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric
